APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artesunate Medicines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Artesunate Medicines Market Outlook and Growth Opportunities 2026

2 January 2026195 pages

Choose your research edition.

Industry ResearchArtesunate Medicines Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Artesunate Medicines Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Artesunate Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artesunate Medicines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Artesunate Medicines Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Artesunate Medicines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Artesunate Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Artesunate Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artesunate Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Artesunate Medicines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Artesunate Medicines market include Shin Poong, Sanofi Aventis, MCW Healthcare, Ipca Laboratories, Fosun Pharma (Guilin), Cipla, Ajanta Pharma and Acino, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Artesunate Medicines market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Artesunate Medicines and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artesunate Medicines revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Artesunate Medicines market.

Artesunate Medicines Segment by Company

Shin Poong

Sanofi Aventis

MCW Healthcare

Ipca Laboratories

Fosun Pharma (Guilin)

Cipla

Ajanta Pharma

Acino

Artesunate Medicines Segment by Type

Monoaromatic Artesunate

Compound Artesunate

Artesunate Medicines Segment by Application

Hospital

Clinic

Other

Artesunate Medicines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Artesunate Medicines status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Artesunate Medicines key companies, revenue, market share, and recent developments.

3. To split the Artesunate Medicines breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Artesunate Medicines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Artesunate Medicines significant trends, drivers, influence factors in global and regions.

6. To analyze Artesunate Medicines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artesunate Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artesunate Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artesunate Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artesunate Medicines industry.

Chapter 3: Detailed analysis of Artesunate Medicines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Artesunate Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Artesunate Medicines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Artesunate Medicines Industry Trends Table 2. Artesunate Medicines Industry Drivers Table 3. Artesunate Medicines Industry Opportunities and Challenges Table 4. Artesunate Medicines Industry Restraints Table 5. Global Artesunate Medicines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Artesunate Medicines Revenue Share by Company (2021-2026) Table 7. Global Artesunate Medicines Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Artesunate Medicines Key Company Manufacturing Base & Headquarters Table 9. Global Artesunate Medicines Company, Product Type & Application Table 10. Global Artesunate Medicines Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Artesunate Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Monoaromatic Artesunate Table 15. Significant Companies of Compound Artesunate Table 16. Global Artesunate Medicines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Artesunate Medicines Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Artesunate Medicines Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Artesunate Medicines Sales Value Share by Type (2021-2026) Table 20. Global Artesunate Medicines Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Clinic Table 23. Significant Companies of Other Table 24. Global Artesunate Medicines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Artesunate Medicines Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Artesunate Medicines Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Artesunate Medicines Sales Value Share by Application (2021-2026) Table 28. Global Artesunate Medicines Sales Value Share by Application (2027-2032) Table 29. Global Artesunate Medicines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Artesunate Medicines Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Artesunate Medicines Sales Value Share by Region (2021-2026) Table 32. Global Artesunate Medicines Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Artesunate Medicines Sales Value Share by Region (2027-2032) Table 34. Global Artesunate Medicines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Artesunate Medicines Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Artesunate Medicines Sales Value Market Share by Country (2021-2026) Table 37. Global Artesunate Medicines Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Artesunate Medicines Sales Value Market Share by Country (2027-2032) Table 39. Shin Poong Company Information Table 40. Shin Poong Business Overview Table 41. Shin Poong Artesunate Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Shin Poong Artesunate Medicines Product Portfolio Table 43. Shin Poong Recent Development Table 44. Sanofi Aventis Company Information Table 45. Sanofi Aventis Business Overview Table 46. Sanofi Aventis Artesunate Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Sanofi Aventis Artesunate Medicines Product Portfolio Table 48. Sanofi Aventis Recent Development Table 49. MCW Healthcare Company Information Table 50. MCW Healthcare Business Overview Table 51. MCW Healthcare Artesunate Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. MCW Healthcare Artesunate Medicines Product Portfolio Table 53. MCW Healthcare Recent Development Table 54. Ipca Laboratories Company Information Table 55. Ipca Laboratories Business Overview Table 56. Ipca Laboratories Artesunate Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Ipca Laboratories Artesunate Medicines Product Portfolio Table 58. Ipca Laboratories Recent Development Table 59. Fosun Pharma (Guilin) Company Information Table 60. Fosun Pharma (Guilin) Business Overview Table 61. Fosun Pharma (Guilin) Artesunate Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Fosun Pharma (Guilin) Artesunate Medicines Product Portfolio Table 63. Fosun Pharma (Guilin) Recent Development Table 64. Cipla Company Information Table 65. Cipla Business Overview Table 66. Cipla Artesunate Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Cipla Artesunate Medicines Product Portfolio Table 68. Cipla Recent Development Table 69. Ajanta Pharma Company Information Table 70. Ajanta Pharma Business Overview Table 71. Ajanta Pharma Artesunate Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Ajanta Pharma Artesunate Medicines Product Portfolio Table 73. Ajanta Pharma Recent Development Table 74. Acino Company Information Table 75. Acino Business Overview Table 76. Acino Artesunate Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Acino Artesunate Medicines Product Portfolio Table 78. Acino Recent Development Table 79. Research Programs/Design for This Report Table 80. Authors List of This Report Table 81. Secondary Sources Table 82. Primary Sources List of Figures Figure 1. Artesunate Medicines Product Image Figure 2. Global Artesunate Medicines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artesunate Medicines Market Size (2021-2032) & (US$ Million) Figure 4. Global Artesunate Medicines Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Monoaromatic Artesunate Image Figure 8. Compound Artesunate Image Figure 9. Global Artesunate Medicines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Artesunate Medicines Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Artesunate Medicines Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Other Image Figure 15. Global Artesunate Medicines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Artesunate Medicines Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Artesunate Medicines Sales Value Share by Application (2021-2032) Figure 18. Global Artesunate Medicines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Artesunate Medicines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Artesunate Medicines Sales Value (2021-2032) & (US$ Million) Figure 21. North America Artesunate Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Artesunate Medicines Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Artesunate Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Artesunate Medicines Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Artesunate Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Artesunate Medicines Sales Value (2021-2032) & (US$ Million) Figure 27. South America Artesunate Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Artesunate Medicines Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Artesunate Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Artesunate Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Artesunate Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Artesunate Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Monoaromatic Artesunate
  • Compound Artesunate
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Shin Poong
  • Sanofi Aventis
  • MCW Healthcare
  • Ipca Laboratories
  • Fosun Pharma (Guilin)
  • Cipla
  • Ajanta Pharma
  • Acino

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Artesunate Medicines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Artesunate Medicines Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Artesunate Medicines Market Dynamics
  1. 2.1 Artesunate Medicines Industry Trends
  2. 2.2 Artesunate Medicines Industry Drivers
  3. 2.3 Artesunate Medicines Industry Opportunities and Challenges
  4. 2.4 Artesunate Medicines Industry Restraints
3 Artesunate Medicines Market by Company
  1. 3.1 Global Artesunate Medicines Company Revenue Ranking in 2025
  2. 3.2 Global Artesunate Medicines Revenue by Company (2021-2026)
  3. 3.3 Global Artesunate Medicines Company Ranking (2024-2026)
  4. 3.4 Global Artesunate Medicines Company Manufacturing Base and Headquarters
  5. 3.5 Global Artesunate Medicines Company Product Type and Application
  6. 3.6 Global Artesunate Medicines Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Artesunate Medicines Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Artesunate Medicines Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Artesunate Medicines Market by Type
  1. 4.1 Artesunate Medicines Type Introduction
  2. 4.1.1 Monoaromatic Artesunate
  3. 4.1.2 Compound Artesunate
  4. 4.2 Global Artesunate Medicines Sales Value by Type
  5. 4.2.1 Global Artesunate Medicines Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Artesunate Medicines Sales Value by Type (2021-2032)
  7. 4.2.3 Global Artesunate Medicines Sales Value Share by Type (2021-2032)
5 Artesunate Medicines Market by Application
  1. 5.1 Artesunate Medicines Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Artesunate Medicines Sales Value by Application
  6. 5.2.1 Global Artesunate Medicines Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Artesunate Medicines Sales Value by Application (2021-2032)
  8. 5.2.3 Global Artesunate Medicines Sales Value Share by Application (2021-2032)
6 Artesunate Medicines Regional Value Analysis
  1. 6.1 Global Artesunate Medicines Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artesunate Medicines Sales Value by Region (2021-2032)
  3. 6.2.1 Global Artesunate Medicines Sales Value by Region: 2021-2026
  4. 6.2.2 Global Artesunate Medicines Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Artesunate Medicines Sales Value (2021-2032)
  7. 6.3.2 North America Artesunate Medicines Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Artesunate Medicines Sales Value (2021-2032)
  10. 6.4.2 Europe Artesunate Medicines Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Artesunate Medicines Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Artesunate Medicines Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Artesunate Medicines Sales Value (2021-2032)
  16. 6.6.2 South America Artesunate Medicines Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Artesunate Medicines Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Artesunate Medicines Sales Value Share by Country, 2025 VS 2032
7 Artesunate Medicines Country-level Value Analysis
  1. 7.1 Global Artesunate Medicines Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Artesunate Medicines Sales Value by Country (2021-2032)
  3. 7.2.1 Global Artesunate Medicines Sales Value by Country (2021-2026)
  4. 7.2.2 Global Artesunate Medicines Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Artesunate Medicines Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Artesunate Medicines Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Artesunate Medicines Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Artesunate Medicines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Artesunate Medicines Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Artesunate Medicines Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Artesunate Medicines Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Artesunate Medicines Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Artesunate Medicines Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Artesunate Medicines Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Artesunate Medicines Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Artesunate Medicines Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Artesunate Medicines Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Artesunate Medicines Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Artesunate Medicines Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Artesunate Medicines Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Artesunate Medicines Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Artesunate Medicines Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Artesunate Medicines Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Artesunate Medicines Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Artesunate Medicines Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Artesunate Medicines Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Artesunate Medicines Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Artesunate Medicines Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Artesunate Medicines Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Artesunate Medicines Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Artesunate Medicines Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Artesunate Medicines Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Artesunate Medicines Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Artesunate Medicines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shin Poong
  2. 8.1.1 Shin Poong Company Information
  3. 8.1.2 Shin Poong Business Overview
  4. 8.1.3 Shin Poong Artesunate Medicines Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shin Poong Artesunate Medicines Product Portfolio
  6. 8.1.5 Shin Poong Recent Developments
  7. 8.2 Sanofi Aventis
  8. 8.2.1 Sanofi Aventis Company Information
  9. 8.2.2 Sanofi Aventis Business Overview
  10. 8.2.3 Sanofi Aventis Artesunate Medicines Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Aventis Artesunate Medicines Product Portfolio
  12. 8.2.5 Sanofi Aventis Recent Developments
  13. 8.3 MCW Healthcare
  14. 8.3.1 MCW Healthcare Company Information
  15. 8.3.2 MCW Healthcare Business Overview
  16. 8.3.3 MCW Healthcare Artesunate Medicines Revenue and Gross Margin (2021-2026)
  17. 8.3.4 MCW Healthcare Artesunate Medicines Product Portfolio
  18. 8.3.5 MCW Healthcare Recent Developments
  19. 8.4 Ipca Laboratories
  20. 8.4.1 Ipca Laboratories Company Information
  21. 8.4.2 Ipca Laboratories Business Overview
  22. 8.4.3 Ipca Laboratories Artesunate Medicines Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ipca Laboratories Artesunate Medicines Product Portfolio
  24. 8.4.5 Ipca Laboratories Recent Developments
  25. 8.5 Fosun Pharma (Guilin)
  26. 8.5.1 Fosun Pharma (Guilin) Company Information
  27. 8.5.2 Fosun Pharma (Guilin) Business Overview
  28. 8.5.3 Fosun Pharma (Guilin) Artesunate Medicines Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Fosun Pharma (Guilin) Artesunate Medicines Product Portfolio
  30. 8.5.5 Fosun Pharma (Guilin) Recent Developments
  31. 8.6 Cipla
  32. 8.6.1 Cipla Company Information
  33. 8.6.2 Cipla Business Overview
  34. 8.6.3 Cipla Artesunate Medicines Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cipla Artesunate Medicines Product Portfolio
  36. 8.6.5 Cipla Recent Developments
  37. 8.7 Ajanta Pharma
  38. 8.7.1 Ajanta Pharma Company Information
  39. 8.7.2 Ajanta Pharma Business Overview
  40. 8.7.3 Ajanta Pharma Artesunate Medicines Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ajanta Pharma Artesunate Medicines Product Portfolio
  42. 8.7.5 Ajanta Pharma Recent Developments
  43. 8.8 Acino
  44. 8.8.1 Acino Company Information
  45. 8.8.2 Acino Business Overview
  46. 8.8.3 Acino Artesunate Medicines Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Acino Artesunate Medicines Product Portfolio
  48. 8.8.5 Acino Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst